Im optimistic for a positive outcome
doi: 10.1016/j.cmet.2019.07.013 120 RosenstockJWyshamCFrasJPKanekoSLeeCJFernndez LandLet al
The promising preclinical results have now paved the way for evaluating the use of GLP-1R agonists in clinical studies with neurodegenerative diseases such as Alzheimers disease , Parkinsons disease , stroke , and diabetic neuropathy
The results from this landmark study across 37 countries provide strong evidence that semaglutide can help patients with MASH by not only improving liver health, but also addressing the underlying metabolic issues that contribute to the disease, said Sanyal, who is also a professor of medicine at the VCU School of Medicine
Millions of people now use it
Kovalkovicova N, Sutiakova I, Pistl J, Sutiak V